There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To compare the efficacy and safety of treatment with dapagliflozin versus that with
placebo add-on to saxagliptin plus metformin in patients whose type 2 diabetes is
inadequately controlled with saxagliptin plus metformin treatment.